FDA Inspection 1259792 — MAIA Pharmaceuticals Inc

MAIA Pharmaceuticals Inc — FEI 3011884887

The FDA completed an inspection of MAIA Pharmaceuticals Inc on Jan 31, 2025 in Princeton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jan 31, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Princeton, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.